Barry Canton - 06 Dec 2021 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role: 10%+ Owner
Signature: /s/ Karen Tepichin, Attorney-in-fact
Issuer symbol: DNA
Transactions as of: 06 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 08 Dec 2021, 19:06:55 UTC
Previous filing: 04 Oct 2022
Next filing: 12 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNA	Class A Common Stock	Conversion of derivative security		+200,000			200,000	06 Dec 2021	By Bartholomew Canton Living Trust	F1, F2
transaction	DNA	Class A Common Stock	Gift	$0	-200,000	-100%	$0^*	0	07 Dec 2021	By Bartholomew Canton Living Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNA	Class B Common Stock	Conversion of derivative security		-200,000	-0.28%		70,189,783	06 Dec 2021	Class A Common Stock	200,000		By Bartholomew Canton Living Trust	F2, F3, F4
holding	DNA	Class B Common Stock						3,093,797	06 Dec 2021	Class A Common Stock	3,093,797		Direct	F2
holding	DNA	Class B Common Stock						3,093,797	06 Dec 2021	Class A Common Stock	3,093,797		By Spouse	F2
holding	DNA	Class B Common Stock						70,389,783	06 Dec 2021	Class A Common Stock	70,389,783		By Reshma Padmini Shetty Living Trust	F2
holding	DNA	Class B Common Stock						8,245,491	06 Dec 2021	Class A Common Stock	8,245,491		By Reshma Padmini Shetty GRAT	F2
holding	DNA	Class B Common Stock						8,245,491	06 Dec 2021	Class A Common Stock	8,245,491		By Bartholomew Canton GRAT	F2
holding	DNA	Class B Common Stock						1,291,794	06 Dec 2021	Class A Common Stock	1,291,794		By The Asha S. Canton Irrevocable Trust	F2
holding	DNA	Class B Common Stock						1,291,794	06 Dec 2021	Class A Common Stock	1,291,794		By The Adhira S. Canton Irrevocable Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions being reported herein relate to a charitable donation of shares of Class A Common Stock. The donated shares remain subject to transfer restrictions in accordance with the Issuer's certificate of incorporation.
F2	Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F3	Pursuant to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. ("Legacy Ginkgo"), as contemplated by an agreement and plan of merger, dated May 11, 2021 and amended on May 14, 2021 (the "Merger Agreement"), (a) each share of Class A common stock of Legacy Ginkgo outstanding immediately prior to the effective time of the business combination was converted into approximately 49.080452 shares of the Issuer's Class A Common Stock; and (b) each share of Class B common stock of Legacy Ginkgo outstanding immediately prior to the effective time of the business combination was converted into approximately 49.080452 shares of the Issuer's Class B Common Stock.
F4	Pursuant to the Merger Agreement, each share of Class A common stock of Legacy Ginkgo, each share of Class B common stock of Legacy Ginkgo, each option of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, each award of restricted common stock of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, and each award of restricted stock units of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, in each case outstanding immediately prior to the effective time of the business combination, received a proportional amount of the approximately 188.7 million earn-out shares.